BioSpace News Archive

Hyperthermia Cancer Treatment Market Size to Reach US$ 266 Mn by 2030

According to Report Study, the hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030.

August 5, 2022
·
11 min read
Newborn Screening Market Size to Reach US$ 3.3 Bn by 2030

The newborn screening market is expected to advance at a robust CAGR of 11% during the forecast period.

August 5, 2022
·
10 min read
FDA

FDA Approves First Targeted Therapy for HER2-Low Breast Cancer

Today, the U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.

August 5, 2022
·
4 min read
Genetown

Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, CA, on Thursday, August 11, 2022, which includes a presentation beginning at 4:00 pm PT.

August 5, 2022
·
1 min read
Business

Orthofix Reports Second Quarter 2022 Results

Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended June 30, 2022. Net sales were $118.1 million, earnings per share (“EPS”) was $0.12, and adjusted EPS was $0.08.

August 5, 2022
·
24 min read
Pharm Country

electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be presenting at the Canaccord Genuity 42nd Annual Growth Conference.

August 5, 2022
·
1 min read
Genetown

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 05, 2022

Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the Company’s Board of Directors approved the grant of stock options to purchase an aggregate of 53,000 shares of the Company’s common stock to two new employees on August 2, 2022.

August 5, 2022
·
2 min read
Biotech Bay

Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4

Vaxart, Inc. announced that at its reconvened Annual Meeting of Stockholders on August 4, its stockholders had voted to approve Proposals 2, 3 and 4.

August 5, 2022
·
5 min read
Pharm Country

Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release 5.2.0 of Pinnacle 21 Enterprise, the Company’s flagship software for validating clinical trial data for biosimulation and regulatory submissions.

August 5, 2022
·
2 min read
Business

MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2022.

August 5, 2022
·
16 min read